Is it safe for an adult patient with a prolonged QTc (corrected QT) interval and a history of anxiety or insomnia to use Valerian root?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Valerian Root Safety in Prolonged QTc

Valerian root appears safe to use in patients with prolonged QTc interval, as it is not associated with QT prolongation and has a favorable safety profile, though evidence for efficacy in anxiety is limited. 1, 2

Safety Profile in QTc Prolongation

  • Valerian root does not appear on any guideline lists of QT-prolonging medications and is not mentioned in the ACC/AHA/HRS guidelines for management of patients with ventricular arrhythmias or supraventricular tachycardia as a substance requiring caution in QTc prolongation 3

  • The herb is well-tolerated with infrequent and benign side effects, achieving a Strength of Recommendation (SOR) grade A for safety 1

  • Unlike antipsychotics and antiarrhythmics that require careful monitoring in prolonged QTc, valerian does not carry warnings about cardiac conduction effects 3, 4

Evidence for Anxiety and Sleep Disorders

  • For anxiety disorders, evidence is insufficient to recommend valerian (SOR A), with only one small 4-week RCT (n=36) showing no significant differences between valerian and placebo on HAM-A anxiety scores 1, 5

  • For insomnia, there is limited evidence suggesting some effectiveness in mild-to-moderate cases (SOR B), though studies show contradictory results and methodological limitations 1

  • The Cochrane review concluded there is insufficient evidence to draw conclusions about valerian's efficacy compared to placebo or diazepam for anxiety disorders 5

Documented Adverse Effects (Not Cardiac)

While valerian is generally safe, clinicians should be aware of non-cardiac adverse effects:

  • Hepatotoxicity and nephrotoxicity have been reported with valerian root, along with headaches, chest tightness, mydriasis, abdominal pain, and tremor of hands and feet 2

  • These effects appear related to chronic or long-term use rather than short-term therapeutic administration 2

Clinical Approach for This Patient Population

The primary concern in prolonged QTc is avoiding medications that further prolong the interval, particularly those exceeding 500 ms or increasing QTc by >60 ms from baseline 3, 4:

  • Medications requiring strict avoidance include Class III antiarrhythmics (amiodarone, ibutilide), certain antipsychotics (thioridazine, ziprasidone, haloperidol), and macrolide antibiotics 3, 4

  • Valerian does not fall into these high-risk categories and can be considered if the patient prefers herbal approaches, though efficacy for anxiety remains unproven 1, 5

Safer Evidence-Based Alternatives

If pharmacologic treatment is needed for anxiety in a patient with prolonged QTc:

  • Benzodiazepines (lorazepam) are safe as they do not prolong QTc and are notably absent from all QT-prolonging medication lists 6

  • SSRIs and SNRIs can be used with standard monitoring, as they are not prominently featured in QTc prolongation warnings for anxiety treatment 4

Common Pitfalls

  • Do not assume all herbal products are cardiac-safe: While valerian appears safe for QTc, other supplements may have undocumented cardiac effects 2

  • Avoid polypharmacy with multiple QT-prolonging agents: The risk exponentially increases when combining medications that individually prolong QTc 4

  • Monitor electrolytes: Hypokalemia and hypomagnesemia amplify QTc prolongation risk with any medication and should be corrected before initiating treatment 3, 4

  • Document herbal use: Clinicians should ask patients about herbal medications in a non-judgmental manner, as patients often do not volunteer this information 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antipsychotics and QTc Interval Prolongation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Valerian for anxiety disorders.

The Cochrane database of systematic reviews, 2006

Guideline

Lorazepam Safety in Patients with Prolonged QT Interval

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.